Evidence map›Paper›PMID 38288168›Full record

ArticleCureus2023

Primary Chondrosarcoma of the Right Fourth Rib Resected at the Marginal Margin: A Case Report.

Ryusei Yoshino, Masaki Nakatsubo, Nanami Ujiie, Nana Yoshida, Sayaka Yuzawa, Masahiro Kitada

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ryusei YoshinoThoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Asahikawa, JPN.
Masaki NakatsuboThoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Asahikawa, JPN.
Nanami UjiieThoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Asahikawa, JPN.
Nana YoshidaThoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Asahikawa, JPN.
Sayaka YuzawaDiagnostic Pathology, Asahikawa Medical University Hospital, Asahikawa, JPN.
Masahiro KitadaThoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Asahikawa, JPN.
Asahikawa Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary chondrosarcoma of the ribs is relatively rare, and its basic treatment is surgical resection. In cases with positive resection margins, additional resection is considered, but its indications are unclear. However, reported cases with positive resection margins have been limited. We report a 71-year-old man whose medical checkup revealed an abnormal shadow in the chest. The findings from chest computed tomography, axial T2-weighted magnetic resonance imaging (MRI), and contrast-enhanced MRI led to a diagnosis of chondrosarcoma of the right fourth rib, and surgical resection was performed. The chest wall defect was reconstructed with a Marlex mesh. Postoperative histopathologic diagnosis was grade 2 chondrosarcoma. Gross resection margins, which were marginal, were negative, and the resection margin was grade 1. The patient was followed up without adjuvant therapy and did not undergo additional surgery. For chondrosarcomas with negative gross margins but a marginal margin, additional resection should be considered depending on the histologic grade of the margins. In cases with extensive resection of the chest wall, it is useful to reconstruct the chest wall while paying careful attention to infection control.

Indexed as

chondrosarcomamarginal marginribssurgerythoracic surgery

Identifiers

PMID38288168
PMCPMC10823202
OpenAlexW4390407711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.